Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging,General Medicine
Reference96 articles.
1. Lesko LJ, Atkinson AJ (2001) Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies. Annu Rev Pharmacol Toxicol 41:347–366
2. http://www.fda.govCderregulatorymedImagingdefault.htm . Innovation or Stagnation, Challenge and Opportunity on the critical Path to New Medical Products (March 2004)
3. Woodcock J (2004) A Framework for Biomarker and Surrogate Endpoint Use in Drug Development. http://www.fda.govohrmsdocketsac04slides2004-4079S2_03_Woodcock.ppt
4. Rudin M, Weissleder R (2003) Molecular imaging in drug discovery and development. Nature Rev Drug Disc 2:123–131
5. Caplan LR (2004) Thrombolysis 2004: the good, the bad, and the ugly. Rev Neurol Dis 1:16–26
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献